Answers are grounded in this paper and cite their sources.
While physicians are primarily responsible for Benzodiazepine Receptor Agonist (BZRA) deprescribing, non-physician healthcare professionals (HCPs) can support deprescribing. This study explored barriers to BZRA deprescribing faced by non-physician HCPs. We surveyed 258 HCPs (63.2% nurses) across six European countries using a Theoretical Domain Framework (TDF)-based questionnaire. Logistic regression assessed associations between TDF domains and HCPs’ intention to support deprescribing and their routine support of BZRA deprescribing. Major barriers (defined as TDF items with a mean<3) were found in the Goals (competing priorities), Environmental Context and Resources (time and staff lack), and Social Influence (patient reluctance) domains. Five TDF domains were associated with a stronger intention to support deprescribing: Social/Professional Role and Identity (odds ratio [OR], 3.08; 95% confidence interval [CI], 1.77-5.46); Beliefs about Consequences (OR, 1.91; 95% CI, 1.07-3.34); Memory, Attention and Decision Processing (OR, 1.80; 95% CI, 1.16-2.82); Intention to promote alternatives (OR, 1.63; 95% CI, 1.07-2.49) and Reinforcement (OR, 1.57; 95% CI, 1.08-2.29). Knowledge was the only domain associated with routine BZRA deprescribing support (OR, 1.16; 95% CI, 1.06-1.27). Different categories of HCPs face similar major barriers, but barriers vary across HCP categories and countries. Adapted to contextual differences, targeted interventions may address barriers, enhancing BZRA deprescribing.
No takes yet. Share an insight, caveat, or question.
Shapoval et al. (2025) studied this question.